CATX · ISSUER CIK 728387
Perspective Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Perspective Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $1.6M of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 5 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.6MInsider selling
−$1.6MNet open-market
Sep 8, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 202616:51 | Sep 4, 2026from Sep 3, 2026 | CATX | 10% Owner · +1 joint | S · Sell | $3.13 | −247,932 | 11,273,364 | -2% | −$777K | ||
| Sep 4, 202617:00 | Sep 2, 2026 | CATX | 10% Owner · +1 joint | S · Sell | $3.11 | −42,129 | 11,521,296 | -0% | −$131K | ||
| Sep 4, 202616:58 | Sep 1, 2026from Aug 31, 2026 | CATX | 10% Owner | S · Sell | $3.14 | −113,914 | 11,563,425 | -1% | −$357K | ||
| Sep 3, 202616:54 | Sep 1, 2026 | CATX | 10% Owner | S · Sell | $3.12 | −35,769 | 11,563,425 | -0% | −$112K | ||
| Sep 2, 202616:36 | Aug 31, 2026 | CATX | 10% Owner | S · Sell | $3.14 | −78,145 | 11,599,194 | -1% | −$246K |